Search

Timothy E. Betton

Examiner (ID: 4924)

Most Active Art Unit
1627
Art Unit(s)
1617, 1627, 1614, 1629, 1621
Total Applications
371
Issued Applications
123
Pending Applications
30
Abandoned Applications
218

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4964783 [patent_doc_number] => 20080107603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Neuroprotectant methods, compositions, and screening methods thereof' [patent_app_type] => utility [patent_app_number] => 11/347016 [patent_app_country] => US [patent_app_date] => 2006-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16158 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107603.pdf [firstpage_image] =>[orig_patent_app_number] => 11347016 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/347016
Neuroprotectant methods, compositions, and screening methods thereof Feb 2, 2006 Abandoned
Array ( [id] => 5564779 [patent_doc_number] => 20090137632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Compositions And Methods For Treating Dyslipidemia' [patent_app_type] => utility [patent_app_number] => 11/813909 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2755 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 54 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137632.pdf [firstpage_image] =>[orig_patent_app_number] => 11813909 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/813909
Compositions And Methods For Treating Dyslipidemia Feb 1, 2006 Abandoned
Array ( [id] => 5360539 [patent_doc_number] => 20090035333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'COSMETIC SKIN PREPARATION' [patent_app_type] => utility [patent_app_number] => 11/814695 [patent_app_country] => US [patent_app_date] => 2006-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7254 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20090035333.pdf [firstpage_image] =>[orig_patent_app_number] => 11814695 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/814695
Cosmetic skin preparation Jan 30, 2006 Issued
Array ( [id] => 4860456 [patent_doc_number] => 20080269306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Antidepressant Medicament Comprising Idazoxan and a Selective Serotonin Reuptake Inhibitor' [patent_app_type] => utility [patent_app_number] => 11/793200 [patent_app_country] => US [patent_app_date] => 2005-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4235 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269306.pdf [firstpage_image] =>[orig_patent_app_number] => 11793200 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/793200
Antidepressant Medicament Comprising Idazoxan and a Selective Serotonin Reuptake Inhibitor Dec 26, 2005 Abandoned
Array ( [id] => 4944478 [patent_doc_number] => 20080081804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-03 [patent_title] => 'Combination of Sabcomeline with a Neuroleptic Agent to Treat Psychotic Disorders' [patent_app_type] => utility [patent_app_number] => 11/792849 [patent_app_country] => US [patent_app_date] => 2005-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6107 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20080081804.pdf [firstpage_image] =>[orig_patent_app_number] => 11792849 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/792849
Combination of Sabcomeline with a Neuroleptic Agent to Treat Psychotic Disorders Dec 22, 2005 Abandoned
Array ( [id] => 5656422 [patent_doc_number] => 20060142158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Compositions and methods for anti-transpiration in plants' [patent_app_type] => utility [patent_app_number] => 11/312169 [patent_app_country] => US [patent_app_date] => 2005-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14159 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142158.pdf [firstpage_image] =>[orig_patent_app_number] => 11312169 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/312169
Compositions and methods for anti-transpiration in plants Dec 19, 2005 Issued
Array ( [id] => 5807294 [patent_doc_number] => 20060093648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Hydrogels for orthopedic repair' [patent_app_type] => utility [patent_app_number] => 11/301055 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12106 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20060093648.pdf [firstpage_image] =>[orig_patent_app_number] => 11301055 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/301055
Hydrogels for orthopedic repair Dec 11, 2005 Abandoned
Array ( [id] => 4652152 [patent_doc_number] => 20080039408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Use of Oxypurinol as an Inhibitor of Anti-Neoplastic Agent-Induced Cardiotoxicity' [patent_app_type] => utility [patent_app_number] => 11/792598 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11349 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039408.pdf [firstpage_image] =>[orig_patent_app_number] => 11792598 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/792598
Use of Oxypurinol as an Inhibitor of Anti-Neoplastic Agent-Induced Cardiotoxicity Dec 5, 2005 Abandoned
Array ( [id] => 5742913 [patent_doc_number] => 20060088638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Method of improving sweetness delivery of sucralose' [patent_app_type] => utility [patent_app_number] => 11/294891 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4374 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088638.pdf [firstpage_image] =>[orig_patent_app_number] => 11294891 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/294891
Method of improving sweetness delivery of sucralose Dec 5, 2005 Abandoned
Array ( [id] => 5149576 [patent_doc_number] => 20070049636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 11/293483 [patent_app_country] => US [patent_app_date] => 2005-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12474 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049636.pdf [firstpage_image] =>[orig_patent_app_number] => 11293483 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/293483
Pharmaceutical compositions Dec 1, 2005 Abandoned
Array ( [id] => 4734399 [patent_doc_number] => 20080051379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Compositions and Methods for the Treatment of Peripheral B-Cell Neoplasms' [patent_app_type] => utility [patent_app_number] => 11/792172 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13111 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20080051379.pdf [firstpage_image] =>[orig_patent_app_number] => 11792172 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/792172
Compositions and Methods for the Treatment of Peripheral B-Cell Neoplasms Nov 30, 2005 Abandoned
Array ( [id] => 5693793 [patent_doc_number] => 20060153940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Use of physiologically active fatty acids' [patent_app_type] => utility [patent_app_number] => 11/273464 [patent_app_country] => US [patent_app_date] => 2005-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2909 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153940.pdf [firstpage_image] =>[orig_patent_app_number] => 11273464 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/273464
Use of physiologically active fatty acids Nov 13, 2005 Abandoned
Array ( [id] => 4445120 [patent_doc_number] => 07863311 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Transmucosal veterinary composition comprising detomidine' [patent_app_type] => utility [patent_app_number] => 11/667100 [patent_app_country] => US [patent_app_date] => 2005-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4511 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/863/07863311.pdf [firstpage_image] =>[orig_patent_app_number] => 11667100 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/667100
Transmucosal veterinary composition comprising detomidine Nov 2, 2005 Issued
Array ( [id] => 5786781 [patent_doc_number] => 20060205767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases' [patent_app_type] => utility [patent_app_number] => 11/255103 [patent_app_country] => US [patent_app_date] => 2005-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 73268 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205767.pdf [firstpage_image] =>[orig_patent_app_number] => 11255103 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/255103
Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases Oct 19, 2005 Issued
Array ( [id] => 5662074 [patent_doc_number] => 20060252670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Method of reducing drug-induced adverse side effects in a patient' [patent_app_type] => utility [patent_app_number] => 11/250298 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11660 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252670.pdf [firstpage_image] =>[orig_patent_app_number] => 11250298 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/250298
Method of reducing drug-induced adverse side effects in a patient Oct 12, 2005 Abandoned
Array ( [id] => 4663171 [patent_doc_number] => 20080254078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Chitosan-Based Particles' [patent_app_type] => utility [patent_app_number] => 12/066885 [patent_app_country] => US [patent_app_date] => 2005-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4655 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254078.pdf [firstpage_image] =>[orig_patent_app_number] => 12066885 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/066885
Chitosan-Based Particles Sep 15, 2005 Abandoned
Array ( [id] => 5160454 [patent_doc_number] => 20070173498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Melanin concentrating hormone antagonist' [patent_app_type] => utility [patent_app_number] => 11/224744 [patent_app_country] => US [patent_app_date] => 2005-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 83703 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20070173498.pdf [firstpage_image] =>[orig_patent_app_number] => 11224744 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/224744
Melanin concentrating hormone antagonist Sep 11, 2005 Abandoned
Array ( [id] => 4759975 [patent_doc_number] => 20080312201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Reduced Toxicity Methotrexate Formulations and Methods for Using the Same' [patent_app_type] => utility [patent_app_number] => 11/662375 [patent_app_country] => US [patent_app_date] => 2005-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7577 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312201.pdf [firstpage_image] =>[orig_patent_app_number] => 11662375 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/662375
Reduced Toxicity Methotrexate Formulations and Methods for Using the Same Sep 7, 2005 Abandoned
Array ( [id] => 4675619 [patent_doc_number] => 20080213248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Methods and Systems for Treating Asthma and Other Respiratory Diseases' [patent_app_type] => utility [patent_app_number] => 11/661666 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16352 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213248.pdf [firstpage_image] =>[orig_patent_app_number] => 11661666 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/661666
Methods and Systems for Treating Asthma and Other Respiratory Diseases Sep 1, 2005 Abandoned
Array ( [id] => 5247873 [patent_doc_number] => 20070244107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Method of Treating Atherosclerosis, Dyslipidemias and Related Conditions' [patent_app_type] => utility [patent_app_number] => 11/631741 [patent_app_country] => US [patent_app_date] => 2005-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20164 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244107.pdf [firstpage_image] =>[orig_patent_app_number] => 11631741 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/631741
Method of Treating Atherosclerosis, Dyslipidemias and Related Conditions Aug 23, 2005 Abandoned
Menu